UBS Group’s Amplify Weight Loss Drug & Treatment ETF THNR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$58K	Buy	2,553 +1,955	+327%	+$44.4K	﹤0.01%	6381
2025 Q1	$12.9K	Buy	598 +152	+34%	+$3.27K	﹤0.01%	7167
2024 Q4	$10.1K	Buy	446 +224	+101%	+$5.05K	﹤0.01%	7085
2024 Q3	$5.95K	Buy	+222	New	+$5.95K	﹤0.01%	6803